TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TARS

Tarsus Pharmaceuticals Inc

Healthcare · Biotechnology

78.10$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Tarsus Pharmaceuticals Inc (TARS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 562 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TARS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
2.4 58 172 179 228 265 377 562
2.4 58 171 176 225 256 357 523
2.4 58 168 171 72 225 95 184
2.4 58 168 172 217 227 291 417
0.0 0.0 0.0 0.1 3.6 18 48 87
0.0 176 4.8 3.1 2.6 4.4
0.0 0.3 1.2 0.8 1.0
3.9 8.3 7.4
3.7 64 6.0 12 35 69 152 219
0.2 0.8 5.4 11 15 37 81 136
0.1 0.3 1.3 0.7 0.4 0.6
0.2 0.5 2.2 2.9 5.5 18 28 16
19 30 72 72
-1.4 -6.0 166 167 193 197 225 343
-1.4 -6.0 -33 -47 -109 -245 -360 -427
4.3 20 20 21 25 29 38 42

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?